NCT04779203 (OD/SD) is a clinical trial of Osseodensification Densah Bur in Tooth Loss, sponsored by Jackson Implant Surgery.

Who is sponsoring NCT04779203?

NCT04779203 is sponsored by Jackson Implant Surgery.

What drugs are being tested in NCT04779203?

Interventions in NCT04779203: Osseodensification Densah Bur.

What condition does NCT04779203 study?

NCT04779203 studies Tooth Loss.

Is NCT04779203 still recruiting?

NCT04779203 is currently completed. Last updated 4 March 2021.

Last reviewed 2021-03-04 · How we verify

NCT04779203: OD/SD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study Comparing Osseodensification With Standard Drilling

Completed Last updated 4 March 2021

What this trial tests

trial testing Osseodensification Densah Bur in Tooth Loss in 23 participants. Completed in 18 December 2020.

Timeline

27 July 2020

Primary endpoint
20 November 2020

18 December 2020

Quick facts

Lead sponsor	Jackson Implant Surgery
Status	Completed
Study type	OBSERVATIONAL
Enrollment	23
Start date	27 July 2020
Primary completion	20 November 2020
Estimated completion	18 December 2020
Sites	1 location across United States

Drugs / interventions tested

Osseodensification Densah Bur

Conditions studied

Tooth Loss — all drugs for Tooth Loss →

Sponsor

Jackson Implant Surgery

Who can join

Adults 22 to 80, any sex, with Tooth Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to examine how Osseodensification, a well-defined bone preparation procedure utilizing special densifying burs (a tool to prepare bone) compares to the standard drilling procedure utilizing regular bone drills, to possibly enhance dental implant healing.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Osseodensification effect on implants primary and secondary stability: Multicenter controlled clinical trial.
Bergamo ETP, Zahoui A, Barrera RB, Huwais S, et al · · 2021 · cited 60× · PMID 34047046 · DOI 10.1111/cid.13007
Effectiveness of bone expansion, compacting and densification in narrow alveolar crests: a systematic review and a meta-analysis.
López-Valverde N, López-Valverde A, Blanco JA. · · 2025 · PMID 40635692 · DOI 10.3389/fbioe.2025.1630495

Verify or expand the search:

Other recruiting trials for Tooth Loss

Currently open trials in the same condition.

NCT07393997 — Autogenous Tooth Transplantation With Instrumentally Simulated Open Apex and Platelet-Rich Fibrin · NA · recruiting
NCT07280260 — Clinical Performance of Nobel N1 System · Phase 4 · recruiting
NCT07177521 — Primary Stability and Peri-implant Outcomes of Short Implants in Post-extraction Single-tooth Sites · NA · recruiting
NCT07534514 — Digitally Assisted Immediate Implants in Geriatric Patients · recruiting
NCT06554080 — Survival and Success Rates of External- and Internal- Connection Dental Implants Placed Within the United Kingdom Armed · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04779203 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jackson Implant Surgery
Last refreshed: 4 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04779203.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing